litlas
Log inCreate account

Noopur Raje

Active 1998–2025

214
Papers
37,919
Citations
103
h-index
205
i10-index

Citations

Citations per year for Noopur Raje1988: 1 citations1989: 2 citations1990: 2 citations1993: 1 citations1997: 1 citations1999: 3 citations2000: 14 citations2001: 50 citations2002: 96 citations2003: 98 citations2004: 94 citations2005: 79 citations2006: 98 citations2007: 161 citations2008: 153 citations2009: 178 citations2010: 207 citations2011: 260 citations2012: 312 citations2013: 248 citations2014: 297 citations2015: 272 citations2016: 293 citations2017: 301 citations2018: 305 citations2019: 1,141 citations2020: 1,607 citations2021: 1,707 citations2022: 1,379 citations2023: 1,148 citations2024: 1,915 citations2025: 902 citations2026: 11 citations1991–1992: no citations, so these years are not shown1994–1996: no citations, so these years are not shown1998: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 4,440 citing papers, 28.4% of this breakdownChina: 1,454 citing papers, 9.3% of this breakdownGermany: 945 citing papers, 6.1% of this breakdownItaly: 927 citing papers, 5.9% of this breakdownUnited Kingdom: 814 citing papers, 5.2% of this breakdownFrance: 691 citing papers, 4.4% of this breakdownSpain: 608 citing papers, 3.9% of this breakdownCanada: 464 citing papers, 3% of this breakdownNetherlands: 437 citing papers, 2.8% of this breakdownAustralia: 384 citing papers, 2.5% of this breakdownJapan: 339 citing papers, 2.2% of this breakdownSwitzerland: 309 citing papers, 2% of this breakdown
0%28.4%Other 24.3%

Institutions

Fields

  • Medicine68.8%
  • Biochemistry, Genetics and Molecular Biology23.4%
  • Immunology and Microbiology4.8%
  • Computer Science0.5%
  • Engineering0.4%
  • Chemistry0.4%
  • Other1.7%

Topics

  • Multiple Myeloma Research and Treatments11.6%
  • CAR-T cell therapy research7.2%
  • Protein Degradation and Inhibitors5.5%
  • Peptidase Inhibition and Analysis3.1%
  • Ubiquitin and proteasome pathways2.4%
  • Immune Cell Function and Interaction2.1%
  • Other68.1%

Coauthors

All papers

Open in search
  1. Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma

    Authors: Nikhil C. Munshi, Larry D. Anderson, Nina Shah, Deepu Madduri, Jesús G. Berdeja, Sagar Lonial, Noopur Raje, Yi Lin, David S. Siegel, Albert Oriol, Philippe Moreau, Ibrahim Yakoub‐Agha, Michel Delforge, Michèle Cavo, Hermann Einsele, Hartmut Goldschmidt, Katja Weisel, Alessandro Rambaldi, Donna Reece, Fabio Petrocca, Monica Massaro, Jamie N. Connarn, Shari M. Kaiser, Payal Patel, Liping Huang, Timothy Campbell, Kristen Hege, Jesús F. San Miguel - New England Journal of Medicine 2021 cited by 2,424

  2. Anti-BCMA CAR T-Cell Therapy bb2121 in Relapsed or Refractory Multiple Myeloma

    Authors: Noopur Raje, Jesús G. Berdeja, Yi Lin, David S. Siegel, Sundar Jagannath, Deepu Madduri, Michaela Liedtke, Jacalyn Rosenblatt, Marcela V. Maus, Ashley Turka, Lyh-Ping Lam, Richard A. Morgan, Kevin M. Friedman, Monica Massaro, Julie Wang, Greg Russotti, Zhihong Yang, Timothy Campbell, Kristen Hege, Fabio Petrocca, M. Travis Quigley, Nikhil C. Munshi, James N. Kochenderfer - New England Journal of Medicine 2019 cited by 1,738

  3. Elranatamab in relapsed or refractory multiple myeloma: phase 2 MagnetisMM-3 trial results

    Authors: Alexander M. Lesokhin, Michael H. Tomasson, Bertrand Arnulf, Nizar J. Bahlis, H. Miles Prince, Rubén Niesvizky, Paula Rodríguez‐Otero, Joaquín Martínez‐López, Guenther Koehne, Cyrille Touzeau, Yogesh Jethava, Hang Quach, Julien Depaus, Hisayuki Yokoyama, Afshin Eli Gabayan, Don A. Stevens, Ajay K. Nooka, Salomon Manier, Noopur Raje, Shinsuke Iida, Marc S. Raab, Emma Searle, Eric Leip, Sharon T. Sullivan, Umberto Conte, Mohamed Elmeliegy, Akos Czibere, Andrea Viqueira, Mohamad Mohty - Nature Medicine 2023 cited by 564

  4. Vemurafenib in Multiple Nonmelanoma Cancers with BRAF V600 Mutations

    Authors: David M. Hyman, Igor Puzanov, Vivek Subbiah, Jason E. Faris, Ian Chau, Jean‐Yves Blay, Jürgen Wolf, Noopur Raje, Eli L. Diamond, Antoine Hollebecque, Radj Gervais, Maria Elena Elez-Fernandez, Antoîne Italiano, Ralf‐Dieter Hofheinz, Manuel Hidalgo, Emily Chan, Martin Schüler, Susan Frances Lasserre, Martina Makrutzki, Florin Sirzén, Maria Luisa Veronese, Josep Tabernero, José Baselga - New England Journal of Medicine 2015 cited by 1,734

  5. Daratumumab plus Lenalidomide and Dexamethasone for Untreated Myeloma

    Authors: Thierry Façon, Shaji Kumar, Torben Plesner, Robert Z. Orlowski, Philippe Moreau, Nizar J. Bahlis, Supratik Basu, Hareth Nahi, Cyrille Hulin, Hang Quach, Hartmut Goldschmidt, Michael O’Dwyer, Aurore Perrot, Christopher P. Venner, Katja Weisel, Joseph R. Mace, Noopur Raje, Michel Attal, Mourad Tiab, Margaret Macro, Laurent Frenzel, Xavier Leleu, Tahamtan Ahmadi, Christopher Chiu, Jianping Wang, Rian Van Rampelbergh, Clarissa Uhlar, Rachel Kobos, Ming Qi, Saad Z. Usmani - New England Journal of Medicine 2019 cited by 987

  6. Triplet Therapy, Transplantation, and Maintenance until Progression in Myeloma

    Authors: Paul G. Richardson, Susanna Jacobus, Edie Weller, Hani Hassoun, Sagar Lonial, Noopur Raje, Eva Medvedova, Philip L. McCarthy, Edward N. Libby, Peter M. Voorhees, Robert Z. Orlowski, Larry D. Anderson, Jeffrey A. Zonder, Carter P. Milner, Cristina Gasparetto, Mounzer Agha, Abdullah Khan, David D. Hurd, Krisstina Gowin, Rammurti T. Kamble, Sundar Jagannath, Nitya Nathwani, Melissa Alsina, Robert F. Cornell, Hamza Hashmi, Erica Campagnaro, Astrid C. Andreescu, Teresa Gentile, Michaela Liedtke, Kelly Godby, Adam D. Cohen, Thomas H. Openshaw, Marcelo C. Pasquini, Sergio Giralt, Jonathan L. Kaufman, Andrew J. Yee, Emma C. Scott, Pallawi Torka, Amy Foley, Mariateresa Fulciniti, Kyle Hebert, Mehmet Samur, Kelly Masone, Michelle E. Maglio, Andrea A. Zeytoonjian, Omar Nadeem, Robert Schlossman, Jacob P. Laubach, Claudia E. Paba‐Prada, Irene M. Ghobrial, Aurore Perrot, Philippe Moreau, Hervé Avet‐Loiseau, Michel Attal, Kenneth C. Anderson, Nikhil C. Munshi - New England Journal of Medicine 2022 cited by 463

  7. Monitoring, prophylaxis, and treatment of infections in patients with MM receiving bispecific antibody therapy: consensus recommendations from an expert panel

    Authors: Noopur Raje, Kenneth C. Anderson, Hermann Einsele, Yvonne A. Efebera, Francesca Gay, Sarah P. Hammond, Alexander M. Lesokhin, Sagar Lonial, Heinz Ludwig, Philippe Moreau, Krina K. Patel, Karthik Ramasamy, María‐Victoria Mateos - Blood Cancer Journal 2023 cited by 179

  8. Daratumumab, lenalidomide, and dexamethasone versus lenalidomide and dexamethasone alone in newly diagnosed multiple myeloma (MAIA): overall survival results from a randomised, open-label, phase 3 trial

    Authors: Thierry Façon, Shaji Kumar, Torben Plesner, Robert Z. Orlowski, Philippe Moreau, Nizar J. Bahlis, Supratik Basu, Hareth Nahi, Cyrille Hulin, Hang Quach, Hartmut Goldschmidt, Michael O’Dwyer, Aurore Perrot, Christopher P. Venner, Katja Weisel, Joseph R. Mace, Noopur Raje, Mourad Tiab, Margaret Macro, Laurent Frenzel, Xavier Leleu, Tahamtan Ahmadi, Jianping Wang, Rian Van Rampelbergh, Clarissa Uhlar, Brenda Tromp, Maria Delioukina, Jessica Vermeulen, Saad Z. Usmani - The Lancet Oncology 2021 cited by 363

  9. Cardiovascular Events Among Adults Treated With Chimeric Antigen Receptor T-Cells (CAR-T)

    Authors: Raza M. Alvi, Matthew J. Frigault, Michael G. Fradley, Michael D. Jain, Syed Mahmood, Magid Awadalla, Dae Hyun Lee, Daniel A. Zlotoff, Lili Zhang, Zsófia D. Drobni, Malek Hassan, Emmanuel Bassily, Isaac Rhea, Roohi Ismail‐Khan, Connor P. Mulligan, Dahlia Banerji, Aleksandr Lazaryan, Bijal Shah, Adam Rokicki, Noopur Raje, Julio C. Chávez, Jeremy S. Abramson, Frederick L. Locke, Tomas G. Neilan - Journal of the American College of Cardiology 2019 cited by 344

  10. Elranatamab in relapsed or refractory multiple myeloma: the MagnetisMM-1 phase 1 trial

    Authors: Nizar J. Bahlis, Caitlin Costello, Noopur Raje, Moshe Levy, Bhagirathbhai Dholaria, Melhem Solh, Michael H. Tomasson, Michael A. Damore, Sibo Jiang, Cynthia Basu, Athanasia Skoura, Edward M. Chan, Suzanne Trudel, Andrzej Jakubowiak, Cristina Gasparetto, Michael P. Chu, Andrew Dalovisio, Michaël Sébag, Alexander M. Lesokhin - Nature Medicine 2023 cited by 142

  11. Idecabtagene vicleucel for relapsed and refractory multiple myeloma: post hoc 18-month follow-up of a phase 1 trial

    Authors: Yi Lin, Noopur Raje, Jesús G. Berdeja, David S. Siegel, Sundar Jagannath, Deepu Madduri, Michaela Liedtke, Jacalyn Rosenblatt, Marcela V. Maus, Monica Massaro, Fabio Petrocca, Ashish Yeri, Olivia Finney, Andrea Caia, Zhihong Yang, Nathan Martin, Timothy Campbell, Julie Rytlewski, Jaymes Fuller, Kristen Hege, Nikhil C. Munshi, James N. Kochenderfer - Nature Medicine 2023 cited by 118

  12. International myeloma working group consensus recommendations on imaging in monoclonal plasma cell disorders

    Authors: Jens Hillengaß, Saad Z. Usmani, S. Vincent Rajkumar, Brian G.M. Durie, María‐Victoria Mateos, Sagar Lonial, Cristina João, Kenneth C. Anderson, Ramón García‐Sánz, Eloísa Riva, Juan Du, Niels W.C.J. van de Donk, Jesús G. Berdeja, Evangelos Terpos, Elena Zamagni, Robert A. Kyle, Jesús F. San Miguel, Hartmut Goldschmidt, Sergio Giralt, Shaji Kumar, Noopur Raje, Heinz Ludwig, Enrique M. Ocio, Rik Schots, Hermann Einsele, Fredrik Schjesvold, Wen-Ming Chen, Niels Abildgaard, Brea Lipe, Dominik Dytfeld, Baldeep Wirk, Matthew T. Drake, Michèle Cavo, Juan José Lahuerta, Suzanne Lentzsch - The Lancet Oncology 2019 cited by 496

  13. Consensus guidelines and recommendations for infection prevention in multiple myeloma: a report from the International Myeloma Working Group

    Authors: Noopur Raje, Elias Anaissie, Shaji Kumar, Sagar Lonial, Thomas G Martin, Morie A. Gertz, Amrita Krishnan, Parameswaran Hari, Heinz Ludwig, Elizabeth O’Donnell, Andrew J. Yee, Jonathan L. Kaufman, Adam D. Cohen, Laurent Garderet, Ashutosh F Wechalekar, Evangelos Terpos, Navin Khatry, Rubén Niesvizky, Qing Yi, Douglas Joshua, Tapan Saikia, Nelson Leung, Monika Engelhardt, Mohamad Mothy, Andrew R. Branagan, Ajai Chari, Tony Reiman, Brea Lipe, Joshua Richter, S. Vincent Rajkumar, Jesús F. San Miguel, Kenneth C. Anderson, Edward A. Stadtmauer, Rao Prabhala, Phillip McCarthy, Nikhil C. Munshi - The Lancet Haematology 2022 cited by 191

  14. Neurologic toxicities following adoptive immunotherapy with BCMA-directed CAR T cells

    Authors: Philipp Karschnia, Kevin C. Miller, Andrew J. Yee, Kai Rejeski, P. Connor Johnson, Noopur Raje, Matthew J. Frigault, Jörg Dietrich - Blood 2023 cited by 84

  15. Multiple myeloma cells induce lipolysis in adipocytes and uptake fatty acids through fatty acid transporter proteins

    Authors: Cristina Panaroni, Keertik Fulzele, Tomoaki Mori, Ka Tat Siu, Chukwuamaka Onyewadume, Allison Maebius, Noopur Raje - Blood 2021 cited by 113

  16. Treatment of relapsed and refractory multiple myeloma: recommendations from the International Myeloma Working Group

    Authors: Philippe Moreau, Shaji Kumar, Jesús F. San Miguel, Faith E. Davies, Elena Zamagni, Nizar J. Bahlis, Heinz Ludwig, Joseph Mıkhael, Evangelos Terpos, Fredrik Schjesvold, Thomas G. Martin, Kwee Yong, Brian G.M. Durie, Thierry Façon, Artur Jurczyszyn, Surbhi Sidana, Noopur Raje, Niels W.C.J. van de Donk, Sagar Lonial, Michèle Cavo, Sigurður Y. Kristinsson, Suzanne Lentzsch, Roman Hájek, Kenneth C. Anderson, Cristina João, Hermann Einsele, Pieter Sonneveld, Monika Engelhardt, Rafaël Fonseca, Annette Juul Vangsted, Katja Weisel, Rachid Baz, Vânia Hungria, Jesús G. Berdeja, Fernando Leal da Costa, Ângelo Maiolino, Anders Waage, David H. Vesole, Enrique M. Ocio, Hang Quach, Christoph Driessen, Joan Bladé, Xavier Leleu, Eloísa Riva, P. Leif Bergsagel, Jian Hou, Wee Joo Chng, Ulf‐Henrik Mellqvist, Dominik Dytfeld, Jean‐Luc Harousseau, Hartmut Goldschmidt, Jacob P. Laubach, Nikhil C. Munshi, Francesca Gay, Meral Beksaç, Luciano J. Costa, Martin Kaiser, Parameswaran Hari, Mario Boccadoro, Saad Z. Usmani, Sonja Zweegman, Sarah A. Holstein, Orhan Sezer, Simon J. Harrison, Hareth Nahi, Gordon Cook, María‐Victoria Mateos, S. Vincent Rajkumar, Meletios Α. Dimopoulos, Paul G. Richardson - The Lancet Oncology 2021 cited by 268

  17. BRAF Inhibition in BRAF V600 -Mutant Gliomas: Results From the VE-BASKET Study

    Authors: Thomas Kaley, Mehdi Touat, Vivek Subbiah, Antoine Hollebecque, Jordi Rodón, A. Craig Lockhart, Vicki L. Keedy, Franck Bielle, Ralf‐Dieter Hofheinz, Florence Joly, Jean‐Yves Blay, Ian Chau, Igor Puzanov, Noopur Raje, Jürgen Wolf, Lisa M. DeAngelis, Martina Makrutzki, Todd Riehl, Bethany Pitcher, José Baselga, David M. Hyman - Journal of Clinical Oncology 2018 cited by 331

  18. International Myeloma Working Group immunotherapy committee consensus guidelines and recommendations for optimal use of T-cell-engaging bispecific antibodies in multiple myeloma

    Authors: Paula Rodríguez‐Otero, Saad Z. Usmani, Adam D. Cohen, Niels W.C.J. van de Donk, Xavier Leleu, Jaime Gállego Pérez‐Larraya, Salomon Manier, Ajay K. Nooka, María‐Victoria Mateos, Hermann Einsele, Monique C. Minnema, Michèle Cavo, Benjamin A. Derman, Noemí Puig, Francesca Gay, P. Joy Ho, Wee Joo Chng, Efstathios Kastritis, Gösta Gahrton, Katja Weisel, Chandramouli Nagarajan, Fredik Schjesvold, Joseph Mıkhael, Luciano J. Costa, Noopur Raje, Elena Zamagni, Roman Hájek, Niels Weinhold, Kwee Yong, Jing Christine Ye, Surbhi Sidana, Giampaolo Merlini, Tom Martin, Yi Lin, Ajai Chari, Rakesh Popat, Jonathan L. Kaufman - The Lancet Oncology 2024 cited by 119

  19. Vemurafenib for BRAF V600–Mutant Erdheim-Chester Disease and Langerhans Cell Histiocytosis

    Authors: Eli L. Diamond, Vivek Subbiah, A. Craig Lockhart, Jean‐Yves Blay, Igor Puzanov, Ian Chau, Noopur Raje, Jürgen Wolf, Joseph P. Erinjeri, Jean Torrisi, Mario E. Lacouture, Elena Élez, Ferran Martínez-Valle, Benjamin H. Durham, Maria E. Arcila, Gary A. Ulaner, Omar Abdel‐Wahab, Bethany Pitcher, Martina Makrutzki, Todd Riehl, José Baselga, David M. Hyman - JAMA Oncology 2017 cited by 405

  20. Denosumab versus zoledronic acid in bone disease treatment of newly diagnosed multiple myeloma: an international, double-blind, double-dummy, randomised, controlled, phase 3 study

    Authors: Noopur Raje, Evangelos Terpos, Wolfgang Willenbacher, Kazuyuki Shimizu, Ramón García‐Sánz, Brian G.M. Durie, Wojciech Legieć, Marta Krejčí, Kamel Laribi, Li Zhu, Paul Cheng, Douglas Warner, G. David Roodman - The Lancet Oncology 2018 cited by 441

  21. Tumor-promoting immune-suppressive myeloid-derived suppressor cells in the multiple myeloma microenvironment in humans

    Authors: Güllü Görgün, Gregory Whitehill, Jennifer L. Anderson, Teru Hideshima, Craig Maguire, Jacob P. Laubach, Noopur Raje, Nikhil C. Munshi, Paul G. Richardson, Kenneth C. Anderson - Blood 2013 cited by 387

  22. Phase 1 study of CART-ddBCMA for the treatment of subjects with relapsed and refractory multiple myeloma

    Authors: Matthew J. Frigault, Michael R. Bishop, Jacalyn Rosenblatt, Elizabeth O’Donnell, Noopur Raje, Daniella Cook, Andrew J. Yee, Emma Logan, David Avigan, Andrzej Jakubowiak, Kit L. Shaw, Heather Daley, Sarah Nikiforow, Faith Griffin, Christine Cornwell, Angela Shen, Christopher R. Heery, Marcela V. Maus - Blood Advances 2022 cited by 71

  23. Treatment of Multiple Myeloma: ASCO and CCO Joint Clinical Practice Guideline

    Authors: Joseph Mıkhael, Nofisat Ismaila, Matthew C. Cheung, Caitlin Costello, Madhav V. Dhodapkar, Shaji Kumar, Martha Q. Lacy, Brea Lipe, Richard F. Little, Anna S. Nikonova, James Omel, Namrata Peswani, Anca Prica, Noopur Raje, Rahul Seth, David H. Vesole, Irwin Walker, Alexander C. Whitley, Tanya M. Wildes, Sandy W. Wong, Tom Martin - Journal of Clinical Oncology 2019 cited by 333

  24. Daratumumab plus lenalidomide and dexamethasone in transplant-ineligible newly diagnosed multiple myeloma: frailty subgroup analysis of MAIA

    Authors: Thierry Façon, Gordon Cook, Saad Z. Usmani, Cyrille Hulin, Shaji Kumar, Torben Plesner, Cyrille Touzeau, Nizar J. Bahlis, Supratik Basu, Hareth Nahi, Hartmut Goldschmidt, Hang Quach, Mohamad Mohty, Christopher P. Venner, Katja Weisel, Noopur Raje, Benjamin Hébraud, Karim Belhadj‐Merzoug, Lotfi Benboubker, Olivier Decaux, Salomon Manier, Denis Caillot, Jon Ukropec, Huiling Pei, Rian Van Rampelbergh, Clarissa Uhlar, Rachel Kobos, Sonja Zweegman - Leukemia 2022 cited by 123